ERBB2 and breast carcinoma: The breast cancer cell lines with various expression levels of the HER2/neu receptor protein such as MDA-MB-231 with HER2–, MDA-MB-435s with moderate HER2+, and SK-BR-3 with HER2+ overexpression was studied using RS [37,38].